The Patent Finder

Oncothyreon Canada Inc.

Also on record
Records under this name other than patents Oncothyreon Canada Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Oncothyreon Canada Inc.

PatentTitleStatus Expires Confidence
US 7,491,707Synthetic lipid-a-analogs and uses thereof
Formerly held
Term ended
Term ended Nov 15, 2020 · From the USPTO record
Term endedTerm ended Nov 15, 2020From the USPTO record
US 8,198,400Vaccine for modulating between T1 and T2 immune responses
Formerly held
Lapsed on the fee record
Ended Jun 12, 2020 · From the USPTO record
Lapsed on the fee recordEnded Jun 12, 2020From the USPTO record
US 8,097,593Lipid A and other carbohydrate ligand analogs
Formerly held
Lapsed on the fee record
Ended Jan 17, 2020 · From the USPTO record
Lapsed on the fee recordEnded Jan 17, 2020From the USPTO record
US 9,173,929Mucinous glycoprotein (MUC-1) vaccine
Formerly held
Lapsed on the fee record
Ended Nov 3, 2019 · From the USPTO record
Lapsed on the fee recordEnded Nov 3, 2019From the USPTO record
US 6,544,549Multilamellar coalescence vesicles (MLCV) containing biologically active compounds
Formerly held
Term ended
Term ended Sep 25, 2019 · From the USPTO record
Term endedTerm ended Sep 25, 2019From the USPTO record
US 8,871,250Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine
Formerly held
Lapsed on the fee record
Ended Oct 28, 2018 · From the USPTO record
Lapsed on the fee recordEnded Oct 28, 2018From the USPTO record
US 6,312,718Vaccine for B-cell malignancies
Formerly held
Term ended
Term ended Oct 27, 2018 · From the USPTO record
Term endedTerm ended Oct 27, 2018From the USPTO record
US 7,820,627Lipid A and other carbohydrate ligand analogs
Formerly held
Lapsed on the fee record
Ended Oct 26, 2018 · From the USPTO record
Lapsed on the fee recordEnded Oct 26, 2018From the USPTO record
US 7,741,297Immunostimulatory, covalently lipidated oligonucleotides
Formerly held
Lapsed on the fee record
Ended Jun 22, 2018 · From the USPTO record
Lapsed on the fee recordEnded Jun 22, 2018From the USPTO record
US 6,600,012Lipid-modified muc-1 derivatives
Formerly held
Term ended
Term ended May 8, 2018 · From the USPTO record
Term endedTerm ended May 8, 2018From the USPTO record
10 of 21 patents shown.
Pro members see all 21.
Pro members: see all 21 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited